nominally significantP < 0.05
For this, we selected the nominally significant hypo- or hypermethylated CpGs (uncorrected P < 0.05) in the discovery step and conducted the overlap step in the pipeline.
For this, we selected the nominally significant hypo- or hypermethylated CpGs (uncorrected P < 0.05) in the discovery step and conducted the overlap step in the pipeline.
There was a marginally significant increase in the proportion of PrCa CpGs in upstream ( P = 0.091), ncRNA intronic ( P = 0.078) and 5’-UTR + intronic + 3’-UTR ( P = 0.074) regions and a near significant decrease in intergenic region ( P = 0.051) compared to the set of all CpGs tested (Supplementary Data 4 ).